Boston, MA - 7 January 2015 – Sciformix Corporation has opened a new office in Manchester, UK. By opening an office in the UK, Sciformix will seek to better service its existing global and European clients with near-shore presence and also build new relationships with potential clients across EMEA to further grow and diversify its client and revenue base.
Manish Soman, President & CEO, Sciformix Corporation commented, “Sciformix’s long term strategy focuses on evolving and enhancing our service and technology offerings, broadening our global reach and growing and diversifying the client and revenue base. Building a European hub will support all of these objectives. With our clients’ growth in emerging markets, it has become increasingly important for us to truly understand the local safety and regulatory challenges our clients face and to become the partner of choice when it comes to outsourcing these activities. Sciformix is such a trusted provider.”
The new office will support all service lines, however, the initial focus will be on Consulting, Safety and Risk Management, Regulatory, and Labelling services.
Sciformix Corporation is a leading Scientific Process Organization (SPO), providing scientific knowledge-based services to pharmaceutical and biopharmaceutical, generics, consumer products, medical devices and other healthcare companies – in the areas of Safety and Risk Management, Clinical Research & Post-Approval Support and Regulatory Affairs. Corporate headquarters is located in Westborough, MA with operations in USA, India and the Philippines.